IgG₃⁺ B cells are associated with the development of multiple sclerosis

Abstract

We have identified previously uncharacterised subsets of IgG₃ ⁺ B cells and shown them to correlate with autoimmune attacks on the central nervous system (CNS). These results highlight the potential for therapies that specifically target IgG₃ ⁺ B cells to impact MS progression.